id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0464-0021,FDA,FDA-2005-N-0464,"Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; ReOpening of Comment Period",Proposed Rule,Extension of Comment Period,2007-02-08T05:00:00Z,2007,2,2007-02-07T05:00:00Z,2007-02-27T04:59:59Z,2016-11-10T15:32:42Z,,0,0,0900006480450d0d
FDA-2005-N-0464-0020,FDA,FDA-2005-N-0464,Letter from FDA/CDER Response to National Committee on Vital,Other,Letter(s),2007-01-29T05:00:00Z,2007,1,,,2016-12-13T21:15:43Z,,0,0,0900006480450ca3
FDA-2005-N-0464-0015,FDA,FDA-2005-N-0464,See FDA-2005-N-0464-0014,Supporting & Related Material,TR-Transcript,2007-01-12T05:00:00Z,2007,1,,,2009-04-15T23:58:47Z,,0,0,0900006480450c43
FDA-2005-N-0464-0014,FDA,FDA-2005-N-0464,"Transcript of Public Meeting:  Proposed Changes to the National Drug Code (NDC) System, December 11, 2006",Other,TR-Transcript,2007-01-12T05:00:00Z,2007,1,,,2017-07-24T15:11:28Z,,0,0,0900006480450c42
FDA-2005-N-0464-0016,FDA,FDA-2005-N-0464,"FDA/CDER - ""Proposed Revised 21 CFR 207 Electronic Drug Registration and Listing Systems (e-DRLS)"" - Testimony",Other,TS-Testimony,2007-01-12T05:00:00Z,2007,1,,,2017-01-18T17:37:35Z,,0,0,0900006480450c44
FDA-2005-N-0464-0017,FDA,FDA-2005-N-0464,Testimony re FDA-2005-N-0464-0016,Supporting & Related Material,Testimony,2007-01-12T05:00:00Z,2007,1,,,2016-12-13T20:44:03Z,,0,0,0900006480450c45